Does ETEPLIRSEN Cause Poor venous access? 162 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 162 reports of Poor venous access have been filed in association with ETEPLIRSEN (Exondys 51). This represents 7.8% of all adverse event reports for ETEPLIRSEN.
162
Reports of Poor venous access with ETEPLIRSEN
7.8%
of all ETEPLIRSEN reports
0
Deaths
3
Hospitalizations
How Dangerous Is Poor venous access From ETEPLIRSEN?
Of the 162 reports, 3 (1.9%) required hospitalization.
Is Poor venous access Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ETEPLIRSEN. However, 162 reports have been filed with the FAERS database.
What Other Side Effects Does ETEPLIRSEN Cause?
Product dose omission issue (641)
No adverse event (503)
Intentional dose omission (259)
Device issue (156)
Pyrexia (85)
Covid-19 (83)
Malaise (56)
Cough (53)
Fall (53)
Pneumonia (51)
What Other Drugs Cause Poor venous access?
VEDOLIZUMAB (1,043)
INFLIXIMAB (917)
INFLIXIMAB-DYYB (782)
ECULIZUMAB (555)
HUMAN IMMUNOGLOBULIN G (504)
NATALIZUMAB (422)
RITUXIMAB (299)
TOCILIZUMAB (287)
METHOTREXATE (257)
ABATACEPT (249)
Which ETEPLIRSEN Alternatives Have Lower Poor venous access Risk?
ETEPLIRSEN vs ETESEVIMAB
ETEPLIRSEN vs ETHACRYNIC ACID
ETEPLIRSEN vs ETHAMBUTOL
ETEPLIRSEN vs ETHAMBUTOL\ISONIAZID\PYRAZINAMIDE\RIFAMYCIN
ETEPLIRSEN vs ETHANOL